血管新生素和偏差类型在GPCR中诱导结构上不同的活性构造
Laura M Wingler1,2, Meredith A Skiba3, Conor McMahon3
1Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA.
偏差的G蛋白结合受体 (GPCR) 激活特定的途径. 晶体结构揭示了血管素II型1受体 (AT1R) 的重组如何决定向β-arrestin或Gq蛋白的信号偏移.
科学领域:
- 生物化学
- 结构生物学
- 药理学
背景情况:
- 偏差的G蛋白合受体 (GPCRs) 选择性地激活下游信号通路.
- 了解受体-连接体相互作用对于开发向疗法至关重要.
研究的目的:
- 阐明血管激素II型1受体 (AT1R) 的偏向性激动的结构基础.
- 为了比较平衡激动剂 (Angiotensin II) 与偏差类型的结构效应.
主要方法:
- 用X射线结晶学来确定AT1R与三种不同的配体结合的结构.
- 分析受体内由联体诱导的形状变化.
主要成果:
- 在2. 72. 9的AT1R晶体结构得到了angiotensinII和两个β-arrestin偏差类型.
- 血管素II诱导了对联体结合口袋和核心极点网络的显著重新排列,与偏向联体不同.
- 这种极性网络包含一种结位,作为一个影响信号偏差的开关.
结论:
- 结构上的差异解释了AT1R配体的信号配置不同.
- 已识别的极性网络是偏差信号的关键决定因素,可能会使AT1R和其他GPCR产生特定的信号结果.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
09:19Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization
Published on: March 16, 2020
相关概念视频
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
GPCRs Regulate Adenylyl Cylase Activity
Activation and Inactivation of G Proteins
Antihypertensive Drugs: Angiotensin II Receptor Blockers
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
